Aurinia Pharmaceuticals (AUPH)
(Delayed Data from NSDQ)
$6.75 USD
-0.07 (-1.03%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $6.75 0.00 (0.00%) 7:54 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Earnings News For AUPH
-
Aurinia: Q2 Earnings Snapshot
-
Aurinia Pharmaceuticals (AUPH) Q2 Earnings and Revenues Beat Estimates
-
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results
-
Aurinia: Q1 Earnings Snapshot
-
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
-
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
-
Aurinia: Q4 Earnings Snapshot
-
Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates
-
Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
-
Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Tops Revenue Estimates
-
Aurinia: Q3 Earnings Snapshot
-
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
-
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates
-
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2023 Financial and Operational Results
-
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
-
Aurinia: Q1 Earnings Snapshot
-
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
-
Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates
-
Aurinia: Q4 Earnings Snapshot
-
Aurinia Reports Fourth Quarter and Full Year 2022 Financial Results and Company Updates
-
Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: Should You Buy?
-
Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Tops Revenue Estimates
-
Aurinia: Q3 Earnings Snapshot
-
Aurinia Reports Third Quarter and Nine Months 2022 Financial and Operational Results
-
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates